Stock listing
LS Exchange:A2PVB0 Vext Science, Inc. Aktie
German listing (LS Exchange) of Vext Science, Inc. · home listing CSE:VEXT
Follow Vext Science, Inc. into a list and get an email when it puts out news.
Home listing price · CSE:VEXT
$0.175 CAD -0.010 (-5.4%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:VEXT
- Day range
- $0.160 – $0.180 CADNov 20, 2026
- Volume
- 40,200 sharesNov 20, 2026
- Market cap
- $32.52M CADAt the close on Nov 20, 2026 · price × 185.8M shares outstanding
- 52-week range
- $0.160 – $0.400 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $16,387 CADMedian day 40,600 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:VEXT · Home | $0.175 CAD | -0.010 (-5.4%) | 40,200 | $0.180 | $0.180 | $0.160 | $0.185 | Close on Nov 20, 2026 |
| OTC:VEXTF | $0.117 USD | -0.009 (-7.1%) | 16,000 | $0.117 | $0.117 | $0.117 | $0.126 | Close on Nov 20, 2026 |
| Frankfurt:VV5 | €0.102 EUR | -0.006 (-5.6%) | — | €0.108 | €0.108 | €0.102 | €0.108 | Close on Nov 20, 2026 |
| Munich:VV5 | €0.119 EUR | 0.000 (0.0%) | — | €0.119 | €0.119 | €0.119 | €0.119 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · CSE:VEXT · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.175 | -0.010 | -5.4% | $0.180 | $0.180 | $0.160 | 40,200 | |
| $0.185 | +0.010 | +5.7% | $0.180 | $0.185 | $0.180 | 4,150 | |
| $0.175 | 0.000 | 0.0% | $0.175 | $0.175 | $0.175 | 2,000 | |
| $0.175 | -0.005 | -2.8% | $0.185 | $0.185 | $0.175 | 8,500 | |
| $0.180 | -0.025 | -12.2% | $0.205 | $0.210 | $0.180 | 122,500 | |
| $0.205 | -0.015 | -6.8% | $0.215 | $0.225 | $0.200 | 106,000 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 0 | |
| $0.220 | +0.015 | +7.3% | $0.210 | $0.220 | $0.210 | 34,500 | |
| $0.205 | -0.020 | -8.9% | $0.215 | $0.215 | $0.190 | 17,500 | |
| $0.225 | +0.025 | +12.5% | $0.200 | $0.225 | $0.190 | 19,050 | |
| $0.200 | -0.020 | -9.1% | $0.225 | $0.225 | $0.200 | 141,010 | |
| $0.220 | -0.020 | -8.3% | $0.235 | $0.235 | $0.220 | 87,500 | |
| $0.240 | -0.005 | -2.0% | $0.240 | $0.240 | $0.240 | 3,500 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.245 | $0.245 | 0 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.245 | $0.245 | 2,540 | |
| $0.245 | +0.015 | +6.5% | $0.235 | $0.245 | $0.235 | 41,000 | |
| $0.230 | -0.005 | -2.1% | $0.235 | $0.235 | $0.230 | 8,500 | |
| $0.235 | +0.005 | +2.2% | $0.230 | $0.235 | $0.230 | 75,000 | |
| $0.230 | -0.020 | -8.0% | $0.245 | $0.245 | $0.230 | 44,500 | |
| $0.250 | -0.010 | -3.8% | $0.260 | $0.260 | $0.250 | 24,500 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.260 | 600 | |
| $0.260 | +0.005 | +2.0% | $0.260 | $0.260 | $0.260 | 3,000 | |
| $0.255 | +0.005 | +2.0% | $0.255 | $0.255 | $0.255 | 17,000 | |
| $0.250 | +0.010 | +4.2% | $0.245 | $0.250 | $0.245 | 5,000 | |
| $0.240 | -0.005 | -2.0% | $0.245 | $0.245 | $0.240 | 10,500 | |
| $0.245 | +0.005 | +2.1% | $0.245 | $0.245 | $0.240 | 7,500 | |
| $0.240 | +0.010 | +4.3% | $0.235 | $0.245 | $0.230 | 86,500 | |
| $0.230 | -0.030 | -11.5% | $0.260 | $0.260 | $0.230 | 131,500 | |
| $0.260 | +0.015 | +6.1% | $0.250 | $0.260 | $0.250 | 15,000 | |
| $0.245 | +0.010 | +4.3% | $0.235 | $0.245 | $0.235 | 13,518 | |
| $0.235 | +0.005 | +2.2% | $0.230 | $0.235 | $0.230 | 19,000 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.230 | 50,500 | |
| $0.230 | +0.005 | +2.2% | $0.230 | $0.230 | $0.230 | 10,500 | |
| $0.225 | 0.000 | 0.0% | $0.225 | $0.235 | $0.210 | 155,520 | |
| $0.225 | -0.010 | -4.3% | $0.230 | $0.230 | $0.225 | 6,000 | |
| $0.235 | 0.000 | 0.0% | $0.235 | $0.235 | $0.235 | 32,000 | |
| $0.235 | 0.000 | 0.0% | $0.235 | $0.235 | $0.230 | 130,500 | |
| $0.235 | -0.015 | -6.0% | $0.245 | $0.245 | $0.230 | 163,900 | |
| $0.250 | +0.010 | +4.2% | $0.240 | $0.250 | $0.240 | 9,500 | |
| $0.240 | -0.010 | -4.0% | $0.245 | $0.245 | $0.235 | 27,400 | |
| $0.250 | -0.005 | -2.0% | $0.255 | $0.255 | $0.250 | 12,500 | |
| $0.255 | -0.005 | -1.9% | $0.260 | $0.265 | $0.255 | 169,000 | |
| $0.260 | +0.005 | +2.0% | $0.260 | $0.260 | $0.260 | 51,000 | |
| $0.255 | +0.005 | +2.0% | $0.260 | $0.260 | $0.255 | 21,000 | |
| $0.250 | -0.015 | -5.7% | $0.265 | $0.265 | $0.250 | 35,500 | |
| $0.265 | +0.005 | +1.9% | $0.265 | $0.270 | $0.265 | 85,001 | |
| $0.260 | -0.005 | -1.9% | $0.270 | $0.270 | $0.260 | 82,500 | |
| $0.265 | 0.000 | 0.0% | $0.265 | $0.270 | $0.265 | 146,000 | |
| $0.265 | -0.005 | -1.9% | $0.265 | $0.265 | $0.260 | 60,500 | |
| $0.270 | +0.010 | +3.8% | $0.265 | $0.270 | $0.260 | 83,000 | |
| $0.260 | -0.005 | -1.9% | $0.265 | $0.265 | $0.250 | 76,500 | |
| $0.265 | +0.005 | +1.9% | $0.260 | $0.265 | $0.250 | 87,000 | |
| $0.260 | -0.010 | -3.7% | $0.270 | $0.275 | $0.260 | 66,500 | |
| $0.270 | -0.005 | -1.8% | $0.270 | $0.270 | $0.270 | 21,000 | |
| $0.275 | +0.005 | +1.9% | $0.270 | $0.275 | $0.270 | 41,500 | |
| $0.270 | -0.005 | -1.8% | $0.275 | $0.275 | $0.270 | 34,000 | |
| $0.275 | +0.005 | +1.9% | $0.270 | $0.280 | $0.270 | 283,500 | |
| $0.270 | -0.010 | -3.6% | $0.280 | $0.280 | $0.270 | 125,500 | |
| $0.280 | -0.005 | -1.8% | $0.285 | $0.290 | $0.260 | 312,500 | |
| $0.285 | -0.005 | -1.7% | $0.290 | $0.290 | $0.285 | 136,000 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 58,500 | |
| $0.290 | -0.005 | -1.7% | $0.290 | $0.295 | $0.290 | 74,000 | |
| $0.295 | 0.000 | 0.0% | $0.290 | $0.295 | $0.290 | 56,000 | |
| $0.295 | +0.015 | +5.4% | $0.280 | $0.315 | $0.280 | 342,400 |
- Ticker
- LS Exchange:A2PVB0
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Nov 3, 2026
Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million
Latest earnings call · Aug 20, 2026
Vext Science (CSE:VEXT) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 32 slides
Latest news
Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million
Nov 3, 2026
Closed $0.24 (-2.0%) on Nov 3, 2026
Vext Secures Eighth Ohio Dispensary Location, Reaching the State Maximum
Oct 29, 2026
Closed $0.245 (+6.5%) on Oct 29, 2026
Vext Announces Date for Q3 2026 Financial Results Release
Oct 29, 2026
Closed $0.245 (+6.5%) on Oct 29, 2026
Vext Provides Update on Jackson, Ohio Dispensary
Oct 15, 2026
Closed $0.24 (-2.0%) on Oct 16, 2026
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Sep 17, 2026
Closed $0.255 (+2.0%) on Sep 18, 2026
Vext Provides Operational Update on Jackson, Ohio Dispensary
Sep 4, 2026
Closed $0.265 (+1.9%) on Sep 8, 2026
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
Aug 20, 2026
Closed $0.295 (0.0%) on Aug 21, 2026
Vext Announces Date for Q2 2026 Financial Results Release
Aug 12, 2026
Closed $0.27 (0.0%) on Aug 13, 2026
Vext Opens Sixth Ohio Dispensary in Fairfield
Jun 1, 2026
Closed $0.24 (-4.0%) on Jun 2, 2026
Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales
May 21, 2026
Closed $0.28 (+1.8%) on May 21, 2026
Vext Science, Inc. on 6ix
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- News releases
- 18 in the last 12 months · 33 in all · newest Nov 3, 2026 · oldest 2025
- Calls
- 14 calls with a replay · 14 with a transcript · latest Aug 20, 2026
- Decks
- 3 decks · latest August 2026
Where Vext Science, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:VEXT · Home listing | CSE | Canada | CAD |
| OTC:VEXTF | OTC | United States | USD |
| Cboe Canada:VEXT | Cboe Canada | Canada | CAD |
| LS Exchange:A2PVB0 · This page | LS Exchange | Germany | EUR |
| Frankfurt:VV5 | Frankfurt | Germany | EUR |
| gettex:VV5 | gettex | Germany | EUR |
| Lang & Schwarz:A2PVB0 | Lang & Schwarz | Germany | EUR |
| Dusseldorf:VV5 | Dusseldorf | Germany | EUR |
| Munich:VV5 | Munich | Germany | EUR |
| Stuttgart:VV5 | Stuttgart | Germany | EUR |
Valuation
EV/sales 0.8× against a median of 0.8×: 6th lowest of 10 Tobacco & cannabis companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $58.20M CAD
- P/E
- Loss
- EV/sales
- 0.8×
- EV/EBITDA
- 3.3×
- Price/book
- 0.4×
- Gross margin
- 38.6%
- Operating margin
- −7.0%
- Net margin
- −28.4%
- Debt to equity
- 0.4×
- Beta vs S&P/TSX Composite
- 0.10
Tobacco & cannabis: the 10 companies nearest in size, of 97 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Vext Science, Inc. · CSE:VEXT | US$22.68M | US$40.58M | n/a | 0.8× | 3.3× | 0.4× | −28.4% | 0.4× | 0.10 |
| LEEF Brands Inc · CSE:LEEF | US$43.68M | US$37.79M | n/a | 1.1× | n/a | 10.4× | −38.3% | 0.0× | 0.61 |
| Little Green Pharma Ltd. · ASX:LGP | US$36.17M | US$38.34M | n/a | 1.4× | 31.3× | 0.7× | −3.3% | 0.1× | n/a |
| iAnthus Capital Holdings, Inc. · CSE:IAN | US$24.32M | US$226.4M | n/a | 1.6× | n/a | n/a | −39.3% | n/a | 0.00 |
| Charlie's Holdings, Inc. · OTC:CHUC | US$23.85M | US$23.49M | n/a | 1.0× | n/a | 17.1× | −19.4% | 0.0× | 0.22 |
| Planet 13 Holdings Inc · CSE:PLTH | US$22.21M | US$27.45M | n/a | 0.3× | n/a | 0.7× | −26.7% | 0.3× | 0.76 |
| RYTHM, Inc. · NASDAQ:RYM | US$20.88M | US$53.26M | 3.0× | 0.8× | 13,314× | 0.5× | 9.8% | 1.9× | 1.80 |
| MariMed Inc. · CSE:MRMD | US$19.82M | US$91.35M | n/a | 0.6× | 15.2× | 0.5× | −9.3% | 2.0× | 0.55 |
| Rubicon Organics, Inc. · TSXV:ROMJ | US$18.12M | US$22.94M | n/a | 0.5× | 10.3× | 0.6× | −2.7% | 0.2× | 0.56 |
| MediPharm Labs Corp. · TSX:LABS | US$17.87M | US$11.05M | n/a | 0.4× | n/a | 0.7× | −6.5% | 0.0× | 0.87 |
| Kombinat Konopny SA · NEWCONNECT:KMB | US$11.75M | US$12.82M | n/a | n/a | n/a | 8.6× | n/a | 0.9× | n/a |
| Median of the others | US$21.55M | US$32.62M | 3.0× | 0.8× | 23.3× | 0.7× | −9.3% | 0.2× | 0.59 |
Forecasts
Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.95 CAD · Analysts' mean
- EPS, year to Dec 2026
- -0.042 · 1 analyst
- Revenue, year to Dec 2026
- 54.4M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Eric Offenberger | CHIEF EXECUTIVE OFFICER/COO |
| Trevor Smith | CHIEF FINANCIAL OFFICER |
| Scott Everett | GENERAL COUNSEL AND CORPORATE SECRETARY |
Board
| Director | Role |
|---|---|
| Mark W. Opzoomer | NON-EXECUTIVE CHAIRMAN |
| David Johns | DIRECTOR |
| Eric Offenberger | CHIEF EXECUTIVE OFFICER/COO |
| Spiro A. Phanos | DIRECTOR |
| Terry L. Creighton | DIRECTOR |
| Thai Nguyen | DIRECTOR |
Events
Calls
| Call | When | Status |
|---|---|---|
| Vext Science (CSE:VEXT) Q2 2026 Earnings Call | Thu, Aug 20, 2026 · 5:00 PM ET | Replay |
| Vext Science (CSE:VEXT) Q1 2026 Earnings Call | Thu, May 21, 2026 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q4 2025 Earnings Call | Wed, Apr 29, 2026 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q3 2025 Earnings Call | Thu, Nov 20, 2025 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q2 2025 Earnings Call | Wed, Aug 20, 2025 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q1 2025 Earnings Call | Wed, May 21, 2025 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q4 2024 Earnings Call | Mon, Mar 31, 2025 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q3 2024 Earnings Call | Thu, Nov 21, 2024 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q2 2024 Earnings Call | Tue, Aug 20, 2024 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q1 2024 Earnings Call | Wed, May 29, 2024 · 8:00 AM ET | Replay |
All 14 calls
| Call | When | Status |
|---|---|---|
| Vext Science (CSE:VEXT) Q4 2023 Earnings Call | Fri, May 10, 2024 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q3 2023 Earnings Call | Tue, Nov 28, 2023 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q2 2023 Earnings Call | Wed, Aug 23, 2023 · 8:00 AM ET | Replay |
| Vext Science (CSE:VEXT) Q1 2023 Earnings Call | Thu, May 25, 2023 · 8:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 3, 2026 · Before open | −2.0% |
| Q2 2026 | Aug 20, 2026 · After close | 0.0% |
| Q1 2026 | May 21, 2026 · Before open | +1.8% |
| Q3 2025 | Nov 20, 2025 · Before open | −2.0% |
| Q2 2025 | Aug 20, 2025 · Before open | +5.9% |
| Q1 2025 | May 21, 2025 · Before open | 0.0% |
| Q4 2024 | Mar 31, 2025 · Before open | +2.9% |
| Q3 2024 | Nov 21, 2024 · Before open | −2.6% |
| Q2 2024 | Aug 20, 2024 · Before open | −9.8% |
| Q1 2024 | May 29, 2024 · Before open | −2.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2023 | Nov 28, 2023 · Before open | −4.8% |
| Q2 2023 | Aug 23, 2023 · Before open | −9.1% |
| Q1 2023 | May 25, 2023 · Before open | 0.0% |
| Q4 2022 | Mar 22, 2023 · Before open | −2.0% |
| Q3 2022 | Nov 17, 2022 · Before open | −7.8% |
| Q2 2022 | Aug 24, 2022 · After close | +2.5% |
| Q1 2022 | Apr 20, 2022 · Before open | 0.0% |
| Q3 2021 | Nov 18, 2021 · Before open | −2.5% |
| Quarter to Jun 30, 2021 | Aug 24, 2021 · Before open | +4.2% |
| Quarter to Mar 31, 2021 | Apr 15, 2021 · Before open | −5.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 32 slides | August 2026 |
| Q1 2026 Earnings Presentation | Earnings | 6 slides | May 21, 2026 |
| Q1 2023 Earnings Presentation | Earnings | 22 slides | May 25, 2023 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.4M | 36.0M | 34.8M | 35.4M | 37.2M | 25.2M | 22.3M | 18.5M | 14.8M |
| Cost of revenue | 36.9M | 27.0M | 22.8M | 12.3M | 20.8M | 15.3M | 13.0M | 9.30M | 6.60M |
| Gross profit | 14.5M | 8.98M | 12.0M | 23.1M | 16.4M | 9.90M | 9.37M | 9.17M | 8.25M |
| Research and development | 150.1K | 158.7K | 113.0K | 107.4K | 70.8K | ||||
| Selling, general and administrative | 14.9M | 14.3M | 13.8M | 9.82M | 5.77M | 5.10M | 5.21M | 2.84M | 2.17M |
| Operating income | -6.94M | -11.2M | -7.84M | 9.28M | 9.21M | 3.23M | 3.58M | 5.63M | 5.72M |
| Depreciation and amortization | 15.9M | 15.2M | 9.59M | 6.43M | 3.29M | 2.14M | 833.3K | 566.8K | 414.2K |
| EBITDA | 8.94M | 4.00M | 1.75M | 15.7M | 12.5M | 5.37M | 4.42M | 6.20M | 6.13M |
| Interest expense | 4.48M | 3.92M | 3.81M | 2.05M | 2.23M | 745.0K | 64.6K | 59.4K | 0 |
| Income before tax | -15.2M | -21.1M | 3.36M | 6.70M | 6.82M | 2.64M | 3.67M | 4.88M | 5.64M |
| Income tax | 1.83M | 514.0K | 874.9K | 1.13M | 1.53M | ||||
| Net income | -18.0M | -22.4M | 4.40M | 10.9M | 4.99M | 2.13M | 2.79M | 3.75M | 4.11M |
| Earnings per share, basic | -0.07 | -0.09 | 0.02 | 0.07 | 0.07 | 0.04 | 0.12 | 0.20 | 0.22 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.08M | 4.62M | 8.72M | 5.93M | 6.47M | 1.75M | 7.29M | 3.39M | 0 |
| Short-term investments | 144.6K | 122.0K | |||||||
| Receivables | 1.23M | 875.0K | 1.26M | 3.12M | 21.8M | 17.2M | 16.8M | 13.4M | 9.23M |
| Inventory | 7.47M | 13.3M | 13.3M | 13.8M | 214.9K | 857.3K | 0 | 74.0K | 279.6K |
| Current assets | 16.8M | 26.4M | 41.3M | 51.9M | 31.2M | 24.0M | 24.8M | 17.2M | 9.52M |
| Property, plant and equipment | 29.0M | 12.7M | 8.81M | 4.08M | 3.47M | ||||
| Goodwill | 2.07M | 5.14M | 2.07M | 461.8K | 461.8K | 461.8K | |||
| Total assets | 120.5M | 137.0M | 149.6M | 120.5M | 83.7M | 55.5M | 38.8M | 23.4M | 13.8M |
| Accounts payable | 5.26M | 3.74M | 2.04M | 1.70M | 1.37M | 495.3K | 322.1K | 215.0K | 163.2K |
| Current liabilities | 28.5M | 17.9M | 14.0M | 15.7M | 9.74M | 8.83M | 2.37M | 2.65M | 1.43M |
| Long-term debt | 23.5M | 31.1M | 30.1M | 31.5M | 7.43M | 4.59M | 5.38M | 161.7K | 984.1K |
| Total liabilities | 65.2M | 61.2M | 54.6M | 48.6M | 24.3M | 19.1M | 13.1M | 6.43M | 5.07M |
| Shareholders' equity | 55.4M | 75.7M | 95.0M | 71.9M | 59.4M | 36.3M | 25.7M | 17.0M | 8.77M |
| Shares outstanding | 247.7M | 247.4M | 217.5M | 149.0M | 70.6M | 47.4M | 22.5M | 18.7M | 18.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 11.7M | 3.29M | 4.42M | 5.72M | 11.7M | 3.10M | -393.3K | 2.41M | 1.87M |
| Capital spending | -3.57M | -1.47M | -2.74M | -8.86M | -18.8M | -4.06M | -5.26M | -1.50M | -1.13M |
| Free cash flow | 8.14M | 1.82M | 1.69M | -3.14M | -7.10M | -964.9K | -5.65M | 906.7K | 737.2K |
| Cash from investing | -27.1M | -12.9M | -5.41M | -1.42M | -1.13M | ||||
| Cash from financing | -5.60M | -1.95M | 3.19M | 24.1M | 20.1M | 4.26M | 9.70M | 2.58M | -1.07M |
| Change in cash | 458.0K | -4.09M | 2.79M | -533.3K | 4.72M | -5.55M | 3.90M | 3.57M | -330.8K |
Cap table
Built by 6ix from Vext Science, Inc.’s releases · as of Sep 30, 2026
- Common shares
- 185,816,341
- Fully diluted
- 185,816,341
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 185,816,341 | Sep 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 185,816,341 |
| Sep 30, 2026 | 247,707,041 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Johns | DIRECTOR · Since at least Nov 5, 2026 |
| Eric Offenberger | CHIEF EXECUTIVE OFFICER/COO · Since at least Nov 3, 2026 |
| Mark W. Opzoomer | NON-EXECUTIVE CHAIRMAN · Since at least Nov 5, 2026 |
| Scott Everett | GENERAL COUNSEL AND CORPORATE SECRETARY · Since at least Nov 5, 2026 |
| Spiro A. Phanos | DIRECTOR · Since at least Nov 5, 2026 |
| Terry L. Creighton | DIRECTOR · Since at least Nov 4, 2026 |
| Thai Nguyen | DIRECTOR · Since at least Nov 5, 2026 |
| Trevor Smith | CHIEF FINANCIAL OFFICER · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Vext Science, Inc.